ALISON MCCANN: Open Payments
NPI 1538612726 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 24 payments from 10 companies in 2025. Trend: 2023 $1,225 · 2024 $1,167 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $93 |
| Organogenesis Inc. | 4 | $84 |
| Lilly USA, LLC | 4 | $83 |
| Novo Nordisk Inc | 3 | $67 |
| Alkermes, Inc. | 2 | $53 |
| Medtronic, Inc. | 1 | $52 |
| Smith+Nephew, Inc. | 2 | $41 |
| Eisai Inc. | 1 | $30 |
| EBI, LLC | 1 | $28 |
| Exact Sciences Corporation | 1 | $14 |
Products named: CAPLYTA, AMYVID, VIVITROL, INTELLIS ADAPTIVESTIM, Ozempic, GRAFIX PL, AFFINITY, PURAPLY WOUND MATRIX.
Industry payments across PA — which companies pay providers there.
